Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salmeterol vs Tulobuterol Tape in Adult Asthma
NCT00950794Phase 4Completed
- Sponsor
- GSK
- Start
- Sep 2003
- Primary completion
- Feb 2005
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of salmeterol in asthma (2 arms), sponsored by GSK. Primary endpoint: Change in morning Peak Expiratory Flow at 8 weeks. Started Sep 2003; status: completed.
02
Drugs
salmeterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00950794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00950794.